Arena Pharmaceuticals: Analyzing The Eisai Partnership, Financials, And The Way Forward
Read the rest of this article on Long Investing Ideas from Seeking Alpha
Related Videos
-
Dividend Investors: Check Into Energy StocksRecent underperformance has made energy a more interesting sector for dividend investors, says Morningstar's Josh Peters, who recommends this undervalued, utility-like energy name that has strong dividend growth prospects.
-
That Good Dividend Yield Now Might Not Look So Good LaterAlthough the economy needs to improve before the Fed raises key rates, some dividend payers might act as good hedges amid higher rates, while others have something to lose, says Morningstar's Josh Peters.
-
Pharma Looking Defensive AgainPharmaceutical firms have adapted to their patent cliffs better than investors expected, and solid pricing power and improving pipelines are allowing them to push through macro headwinds.
-
Linsanity a Slam Dunk for This FundAriel's David Maley discusses how he finds names for his deep-value strategy and the benefits of investing in a certain sports-related firm.